Treatment of T-ALL patient-derived xenograft (PDX) cells harboring a heterozygous truncating BRCA2 p.Y1710X mutation (Fig 3A) revealed that these cells lacked hypersensitivity to mitomycin C-induced radial chromosome formation (Fig 3B). The gene discussed is BRCA2; the disease is acute lymphoblastic leukemia.